Evidence map›Paper›PMID 37402869›Full record

Observational studyScientific reports2023

Evaluation of medication regimen complexity as a predictor for mortality.

Andrea Sikora, John W Devlin, Mengyun Yu, Tianyi Zhang, Xianyan Chen, Susan E Smith, Brian Murray, Mitchell S Buckley, Sandra Rowe, David J Murphy

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Andrea SikoraDepartment of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, 1120 15th Street, HM-118, Augusta, GA, 30912, USA. sikora@uga.edu.
John W DevlinBouve College of Health Sciences, Northeastern University, Boston, MA, USA.
Mengyun YuDepartment of Statistics, University of Georgia Franklin College of Arts and Sciences, Athens, GA, USA.
Tianyi ZhangDepartment of Statistics, University of Georgia Franklin College of Arts and Sciences, Athens, GA, USA.
Xianyan ChenDepartment of Statistics, University of Georgia Franklin College of Arts and Sciences, Athens, GA, USA.
Susan E SmithDepartment of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, 1120 15th Street, HM-118, Augusta, GA, 30912, USA.
Brian MurrayDepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Mitchell S BuckleyLaJolla Pharmaceuticals, Waltham, USA.
Sandra RoweOregon Health and Science University, Portland, OR, USA.
David J MurphyDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Augusta University · USFranklin College · USBrigham and Women's Hospital · USEmory University · USLa Jolla Pharmaceutical (United States) · USOregon Health & Science University · USUniversity of Georgia · USUniversity of North Carolina at Chapel Hill · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
Artificial intelligence-based health IT tools to optimize critical care pharmacist resources through adverse drug event predictionR01HS029009 · AHRQ · UNIVERSITY OF GEORGIA · PI Andrea Sikora · 2022 to 2026
$1.8M
Machine learning validation of medication regimen complexity for critical care pharmacist resource predictionR21HS028485 · AHRQ · UNIVERSITY OF GEORGIA · PI SIKORA, ANDREA · 2022 to 2023
$294k
AHRQ HHS R01 HS029009AHRQ HHS R01HS029009AHRQ HHS R21 HS028485NCATS NIH HHS UL1 TR002489NCATS NIH HHS UM1 TR004406
6 · The paper itself

Abstract

While medication regimen complexity, as measured by a novel medication regimen complexity-intensive care unit (MRC-ICU) score, correlates with baseline severity of illness and mortality, whether the MRC-ICU improves hospital mortality prediction is not known. After characterizing the association between MRC-ICU, severity of illness and hospital mortality we sought to evaluate the incremental benefit of adding MRC-ICU to illness severity-based hospital mortality prediction models. This was a single-center, observational cohort study of adult intensive care units (ICUs). A random sample of 991 adults admitted ≥ 24 h to the ICU from 10/2015 to 10/2020 were included. The logistic regression models for the primary outcome of mortality were assessed via area under the receiver operating characteristic (AUROC). Medication regimen complexity was evaluated daily using the MRC-ICU. This previously validated index is a weighted summation of medications prescribed in the first 24 h of ICU stay [e.g., a patient prescribed insulin (1 point) and vancomycin (3 points) has a MRC-ICU = 4 points]. Baseline demographic features (e.g., age, sex, ICU type) were collected and severity of illness (based on worst values within the first 24 h of ICU admission) was characterized using both the Acute Physiology and Chronic Health Evaluation (APACHE II) and the Sequential Organ Failure Assessment (SOFA) score. Univariate analysis of 991 patients revealed every one-point increase in the average 24-h MRC-ICU score was associated with a 5% increase in hospital mortality [Odds Ratio (OR) 1.05, 95% confidence interval 1.02-1.08, p = 0.002]. The model including MRC-ICU, APACHE II and SOFA had a AUROC for mortality of 0.81 whereas the model including only APACHE-II and SOFA had a AUROC for mortality of 0.76. Medication regimen complexity is associated with increased hospital mortality. A prediction model including medication regimen complexity only modestly improves hospital mortality prediction.

Indexed as

Intensive Care UnitsOrgan Dysfunction ScoresAdultAPACHEHospital MortalityHumansPrognosisRetrospective StudiesROC CurveSeverity of Illness Index

Identifiers

PMID37402869
PMCPMC10319715
OpenAlexW4383187411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.